We evaluated mRNA expression of IGFBP4, IGF1 and IGF1R in thyroid cancers, adenomas and hyperplastic nodules in comparison with their benign counterparts without observing any statistically significant differences (Table 3). Here, IGFBP4 is linked to thyroid gland carcinoma.